Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 281-289

  Lu, Mengji ^a   Hilken, Gero ^a   Kruppenbacher, Johannes ^a   Kemper, Thekla ^a   Schirmbeck, Reinhold ^b   Reimann, Joerg ^b   Roggendorf, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; VIRUS DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HEPATITIS VIRUS; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION; VIRUS EXPRESSION; VIRUS INFECTION; WOODCHUCK;

EID: 0032889271     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.281-289.1999     Document Type: Article

References (11)

1. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. J. Schlicht, P. Fowler, S. Guilhot, and F. V. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88:10445-10449.
2. Bojer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. V. Williams, Y. Refaeli, R. B. Ciccarelli, D. McCallus, L. Coney, and D. B. Weiner. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526-532.
3. Carman, W. F. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J. Virol. Hepat. 4(Suppl. 1):11-20.
4. Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
5. Casares, S., T. D. Brumeanu, A. Bot, and C. A. Bona. 1997. Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus. Viral Immunol. 10:129-136.
6. Chiou, H. L., T. S. Lee, J. Kuo, Y. C. Mau, and M. S. Ho. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J. Gen. Virol. 78:2639-2645.
7. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
8. Cote, P. J., and J. L. Gerin. 1995. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection. Hepatology 22:687-699.
9. Cote, P. J., M. Shapiro, R. E. Engle, H. Popper, R. H. Purcell, and J. L. Gerin. 1986. Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen. J. Virol. 60:895-901.
10. Davis, H. L., M. Mancini, M. L. Michel, and R. G. Whalen. 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14:910-915.
11. Davis, H. L., M. J. McCluskie, J. L. Gerin, and R. H. Purcell. 1996. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA 93:7213-7218.